Literature DB >> 19237534

Phosphorylation by cyclin C/cyclin-dependent kinase 2 following mitogenic stimulation of murine fibroblasts inhibits transcriptional activity of LSF during G1 progression.

Utsav H Saxena1, Christina M H Powell, Jill K Fecko, Roxanne Cacioppo, Hubert S Chou, Geoffrey M Cooper, Ulla Hansen.   

Abstract

Transcription factor LSF is required for progression from quiescence through the cell cycle, regulating thymidylate synthase (Tyms) expression at the G(1)/S boundary. Given the constant level of LSF protein from G(0) through S, we investigated whether LSF is regulated by phosphorylation in G(1). In vitro, LSF is phosphorylated by cyclin E/cyclin-dependent kinase 2 (CDK2), cyclin C/CDK2, and cyclin C/CDK3, predominantly on S309. Phosphorylation of LSF on S309 is maximal 1 to 2 h after mitogenic stimulation of quiescent mouse fibroblasts. This phosphorylation is mediated by cyclin C-dependent kinases, as shown by coimmunoprecipitation of LSF and cyclin C in early G(1) and by abrogation of LSF S309 phosphorylation upon suppression of cyclin C with short interfering RNA. Although mouse fibroblasts lack functional CDK3 (the partner of cyclin C in early G(1) in human cells), CDK2 compensates for this absence. By transient transfection assays, phosphorylation at S309, mediated by cyclin C overexpression, inhibits LSF transactivation. Moreover, overexpression of cyclin C and CDK3 inhibits induction of endogenous Tyms expression at the G(1)/S transition. These results identify LSF as only the second known target (in addition to pRb) of cyclin C/CDK activity during progression from quiescence to early G(1). Unexpectedly, this phosphorylation prevents induction of LSF target genes until late G(1).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19237534      PMCID: PMC2668376          DOI: 10.1128/MCB.00687-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  The ubiquitously expressed DNA-binding protein late SV40 factor binds Ig switch regions and represses class switching to IgA.

Authors:  Elise E Drouin; Carol E Schrader; Janet Stavnezer; Ulla Hansen
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

Review 2.  Sibling rivalry in the E2F family.

Authors:  Jeffrey M Trimarchi; Jacqueline A Lees
Journal:  Nat Rev Mol Cell Biol       Date:  2002-01       Impact factor: 94.444

3.  Retroviral expression in embryonic stem cells and hematopoietic stem cells.

Authors:  S R Cherry; D Biniszkiewicz; L van Parijs; D Baltimore; R Jaenisch
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 4.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

5.  Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors.

Authors:  L Ramamurthy; V Barbour; A Tuckfield; D R Clouston; D Topham; J M Cunningham; S M Jane
Journal:  J Biol Chem       Date:  2000-09-19       Impact factor: 5.157

6.  Cdk2 knockout mice are viable.

Authors:  Cyril Berthet; Eiman Aleem; Vincenzo Coppola; Lino Tessarollo; Philipp Kaldis
Journal:  Curr Biol       Date:  2003-10-14       Impact factor: 10.834

7.  Mammalian transcription factor LSF is a target of ERK signaling.

Authors:  Zrinka Pagon; Janet Volker; Geoffrey M Cooper; Ulla Hansen
Journal:  J Cell Biochem       Date:  2003-07-01       Impact factor: 4.429

8.  Functional conservation between members of an ancient duplicated transcription factor family, LSF/Grainyhead.

Authors:  Kavitha Venkatesan; Heather R McManus; Craig C Mello; Temple F Smith; Ulla Hansen
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

9.  Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression.

Authors:  Paola Bruni; Giuseppina Minopoli; Tiziana Brancaccio; Maria Napolitano; Raffaella Faraonio; Nicola Zambrano; Ulla Hansen; Tommaso Russo
Journal:  J Biol Chem       Date:  2002-06-27       Impact factor: 5.157

10.  A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene.

Authors:  X Ye; C Zhu; J W Harper
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  14 in total

1.  Prolyl isomerase Pin1 regulates transcription factor LSF (TFCP2) by facilitating dephosphorylation at two serine-proline motifs.

Authors:  Utsav H Saxena; Laura Owens; Julie R Graham; Geoffrey M Cooper; Ulla Hansen
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

2.  Dose- and time-dependent expression patterns of zebrafish orthologs of selected E2F target genes in response to serum starvation/replenishment.

Authors:  Ceren Sucularli; Serif Senturk; Mehmet Ozturk; Ozlen Konu
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

3.  Late SV40 factor: a key mediator of Notch signaling in human hepatocarcinogenesis.

Authors:  Ren-Hua Fan; Jing Li; Nan Wu; Ping-Sheng Chen
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

4.  Cooperation of deregulated Notch signaling and Ras pathway in human hepatocarcinogenesis.

Authors:  Renhua Fan; Pingsheng Chen; Di Zhao; Jing Long Tong; Jing Li; Feng Liu
Journal:  J Mol Histol       Date:  2011-09-03       Impact factor: 2.611

5.  The transcription factor LSF: a novel oncogene for hepatocellular carcinoma.

Authors:  Prasanna K Santhekadur; Devaraja Rajasekaran; Ayesha Siddiq; Rachel Gredler; Dong Chen; Scott E Schaus; Ulla Hansen; Paul B Fisher; Devanand Sarkar
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

6.  Transcription factors LSF and E2Fs: tandem cyclists driving G0 to S?

Authors:  Ulla Hansen; Laura Owens; Utsav H Saxena
Journal:  Cell Cycle       Date:  2009-07-21       Impact factor: 4.534

7.  Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma.

Authors:  Trevor J Grant; Joshua A Bishop; Lisa M Christadore; Girish Barot; Hang Gyeong Chin; Sarah Woodson; John Kavouris; Ayesha Siddiq; Rachel Gredler; Xue-Ning Shen; Jennifer Sherman; Tracy Meehan; Kevin Fitzgerald; Sriharsa Pradhan; Laura A Briggs; William H Andrews; Devanand Sarkar; Scott E Schaus; Ulla Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-06       Impact factor: 11.205

8.  Cyclin C is a haploinsufficient tumour suppressor.

Authors:  Na Li; Anne Fassl; Joel Chick; Hiroyuki Inuzuka; Xiaoyu Li; Marc R Mansour; Lijun Liu; Haizhen Wang; Bryan King; Shavali Shaik; Alejandro Gutierrez; Alban Ordureau; Tobias Otto; Taras Kreslavsky; Lukas Baitsch; Leah Bury; Clifford A Meyer; Nan Ke; Kristin A Mulry; Michael J Kluk; Moni Roy; Sunkyu Kim; Xiaowu Zhang; Yan Geng; Agnieszka Zagozdzon; Sarah Jenkinson; Rosemary E Gale; David C Linch; Jean J Zhao; Charles G Mullighan; J Wade Harper; Jon C Aster; Iannis Aifantis; Harald von Boehmer; Steven P Gygi; Wenyi Wei; A Thomas Look; Piotr Sicinski
Journal:  Nat Cell Biol       Date:  2014-10-26       Impact factor: 28.824

9.  Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.

Authors:  Xiao Xu; Zhikun Liu; Lin Zhou; Haiyang Xie; Jun Cheng; Qi Ling; Jianguo Wang; Haijun Guo; Xuyong Wei; Shusen Zheng
Journal:  J Exp Clin Cancer Res       Date:  2015-01-22

10.  Regulation of the g1/s transition in hepatocytes: involvement of the cyclin-dependent kinase cdk1 in the DNA replication.

Authors:  Anne Corlu; Pascal Loyer
Journal:  Int J Hepatol       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.